- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06699641
The Kampala Trauma Score in the Outcome of Polytrauma Patients
Cmparison Between the Kampala Trauma Score and the Estimated Injury Severity Score in the Outcome of Polytrauma Patients in the Emergency Departments in Egypt.
The goal of this observational study is to learn about the predictive value of the Kampala Trauma Score in Egypt.
The main question it aims to answer is:
How does the performance of the Kampala Trauma Score compare to the Estimated Injury Severity Score in predicting outcomes for multi-traumatic patients in Egypt? Participants are adult polytrauma patients admitted to the emergency department during the study period.
Study Overview
Status
Conditions
Detailed Description
Two prominent scoring systems used in trauma care are the Kampala Trauma Score (KTS) and the Estimated Injury Severity Score (EISS). The KTS was specifically designed for use in low-resource settings, offering a practical tool for predicting patient outcomes based on readily available clinical data. This score integrates parameters such as age, systolic blood pressure, and Glasgow Coma Scale (GCS) scores, making it suitable for environments where advanced diagnostic tools may be lacking. Previous research has demonstrated the KTS's utility in various resource-limited settings, highlighting its role in effectively stratifying trauma patients and guiding triage decisions.
In contrast, the Estimated Injury Severity Score (EISS) is an adaptation of the Injury Severity Score (ISS), which incorporates both clinical and radiographic data to assess trauma severity comprehensively. The EISS uses an estimated approach to account for the often incomplete or preliminary information available in some clinical settings, aiming to provide a robust prediction of patient outcomes. While it is a more comprehensive tool than the KTS, its reliance on advanced imaging and detailed clinical information may limit its applicability in settings with restricted resources.
This study aims to conduct a cross-sectional comparison of the KTS and EISS to evaluate their relative effectiveness in assessing trauma severity and predicting patient outcomes. The results will provide valuable insights into the optimal use of trauma scoring systems and potentially inform improvements in trauma care practices
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ahmed A Sawy, MBBCH
- Phone Number: +201069369158
- Email: ahmed.16266110@med.aun.edu.eg
Study Contact Backup
- Name: Walaa A Siam, MD
- Phone Number: +201000369868
- Email: Walaa.adel@med.suez.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult polytrauma patients
- Both genders
Exclusion Criteria:
- Patients with incomplete data or those who decline participation.
- Patients with multiple comorbidities.
- Patients managed outside the hospital.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Outcome of polytrauma patients as assessed by the Kampala Trauma Score
Time Frame: From admission to 24 hours post admission
|
From 0 to 10 9-10 = mild 7-8 = moderate <6 = severe
|
From admission to 24 hours post admission
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- The Kampala Trauma Score value
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polytrauma Patients
-
Farid Esmael Haridy MohamedAssiut UniversityNot yet recruitingPolytrauma PatientsEgypt
-
Antalya Training and Research HospitalCompletedPolytrauma | Non-technical Skills | Polytrauma PatientsTurkey (Türkiye)
-
Jessa HospitalActive, not recruitingPolytrauma PatientsBelgium
-
Pakistan Institute of Medical SciencesRecruitingPolytrauma | Resuscitation, Trauma PatientsPakistan
-
University Hospital, BrestRecruitingPatients Undergoing Esophagectomy | Patients with Severe Polytrauma | Patients with Severe Neurological Lesion | Patients with Abdominal InfectionFrance
-
Assiut UniversityNot yet recruiting
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Technical University of MunichRecruiting
-
Technical University of MunichCompleted
-
Medical University of GrazNot yet recruitingPolytrauma | Exanguination | NCTHAustria